Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $412000.0.

  • Treace Medical Concepts' Gains from Investment Securities rose 44933.33% to $412000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$23000.0, marking a year-over-year decrease of 10848.71%. This contributed to the annual value of $7.7 million for FY2024, which is 502.78% up from last year.
  • As of Q3 2025, Treace Medical Concepts' Gains from Investment Securities stood at $412000.0, which was up 44933.33% from $14000.0 recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Gains from Investment Securities ranged from a high of $15.3 million in Q1 2022 and a low of -$850000.0 during Q4 2024
  • Moreover, its 5-year median value for Gains from Investment Securities was $412000.0 (2025), whereas its average is $1.5 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 197317.07% in 2024, then soared by 44933.33% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Gains from Investment Securities stood at $1.8 million in 2021, then tumbled by 30.77% to $1.2 million in 2022, then plummeted by 103.31% to -$41000.0 in 2023, then plummeted by 1973.17% to -$850000.0 in 2024, then soared by 148.47% to $412000.0 in 2025.
  • Its last three reported values are $412000.0 in Q3 2025, $14000.0 for Q2 2025, and $401000.0 during Q1 2025.